Kevin Main
Medical · Gilbert, AZNPI 1194126425
Payments from drug & device makers
Across 728 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Inspire Medical Systems, Inc.$1K
- Mylan Specialty L.p.$690
- plus $8K from 33 others
What the payments were for
- Travel & lodging$8275%
- Food & beverage$14,62193%
- Education$2442%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,692 in reported general payments places this provider in the 95th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 216 | $248,011 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 137 | $120,108 |
| Pirfenidone | 11 | $51,507 |
| Breo ElliptaFluticasone/Vilanterol | 64 | $34,227 |
| Spiriva RespimatTiotropium Bromide | 22 | $15,469 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $14,017 |
| EliquisApixaban | 11 | $12,521 |
| Arnuity ElliptaFluticasone Furoate | 35 | $12,201 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $8,834 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 53 | $8,499 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 247 | $7,522 |
| Wixela InhubFluticasone Propion/Salmeterol | 41 | $6,182 |
| Fluconazole | 52 | $5,608 |
| Advair DiskusFluticasone Propion/Salmeterol | 13 | $4,303 |
| Azelastine Hcl | 107 | $3,503 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $1,438 | $308,455328 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,128 | $128,942163 claims |
| Boehringer IngelheimSpiriva Respimat | $522 | $15,46922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 748 medical providers in Arizona.
Other medical in Gilbert
- Ashley ConwayGilbert$13K
- Tiffany HaynieGilbert$13K
- Kristina ToddGilbert$11K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.